Guoyan Lu

833 total citations
35 papers, 546 citations indexed

About

Guoyan Lu is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Guoyan Lu has authored 35 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Guoyan Lu's work include Vascular Malformations and Hemangiomas (14 papers), Vascular Tumors and Angiosarcomas (7 papers) and Tumors and Oncological Cases (6 papers). Guoyan Lu is often cited by papers focused on Vascular Malformations and Hemangiomas (14 papers), Vascular Tumors and Angiosarcomas (7 papers) and Tumors and Oncological Cases (6 papers). Guoyan Lu collaborates with scholars based in China and United States. Guoyan Lu's co-authors include Yi Ji, Kaiying Yang, Siyuan Chen, Bo Xiang, Zhicheng Xu, Gang Yang, Xingtao Liu, Feiteng Kong, Lina Qiao and Jiangyuan Zhou and has published in prestigious journals such as Scientific Reports, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Guoyan Lu

33 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoyan Lu China 13 396 171 121 120 73 35 546
Kiyofumi Yamakawa Japan 13 287 0.7× 66 0.4× 85 0.7× 35 0.3× 128 1.8× 32 706
Satoshi Tani Japan 17 646 1.6× 233 1.4× 88 0.7× 37 0.3× 227 3.1× 96 1.0k
Bo Jia China 13 98 0.2× 177 1.0× 38 0.3× 29 0.2× 64 0.9× 40 541
Hiraku Kameda Japan 14 198 0.5× 66 0.4× 33 0.3× 47 0.4× 18 0.2× 69 629
Metin Özgen Türkiye 14 118 0.3× 50 0.3× 25 0.2× 61 0.5× 128 1.8× 59 690
Sayuri Tanaka Japan 12 66 0.2× 119 0.7× 79 0.7× 78 0.7× 22 0.3× 41 509
Nithya Krishnan United States 16 149 0.4× 107 0.6× 16 0.1× 40 0.3× 41 0.6× 43 695
Yu Meng China 13 134 0.3× 70 0.4× 18 0.1× 32 0.3× 26 0.4× 40 543
Hedieh Moradi Tabriz Iran 11 98 0.2× 44 0.3× 21 0.2× 36 0.3× 40 0.5× 42 345
Tae Sik Jung South Korea 13 206 0.5× 45 0.3× 30 0.2× 29 0.2× 38 0.5× 38 531

Countries citing papers authored by Guoyan Lu

Since Specialization
Citations

This map shows the geographic impact of Guoyan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyan Lu more than expected).

Fields of papers citing papers by Guoyan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyan Lu. The network helps show where Guoyan Lu may publish in the future.

Co-authorship network of co-authors of Guoyan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoyan Lu. A scholar is included among the top collaborators of Guoyan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoyan Lu. Guoyan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yulin, et al.. (2025). Secondary hemophagocytic lymphohistiocytosis in a 5-month-old infant with IBD post-COVID-19: a case report. Frontiers in Pediatrics. 13. 1536066–1536066.
2.
Yang, Min, T. Qiu, Jiangyuan Zhou, et al.. (2024). Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases. Hepatology International. 19(3). 682–691. 1 indexed citations
3.
Lu, Guoyan, Xing Li, Jie Tang, et al.. (2024). Mycoplasma infection aggravates cardiac involvements in Kawasaki diseases: a retrospective study. Frontiers in Immunology. 14. 1310134–1310134. 2 indexed citations
5.
Peng, Mou, Sichen Duan, Guoyan Lu, et al.. (2023). A novel homozygous variant of TMEM260 induced cardiac malformation and neurodevelopmental abnormality: case report and literature review. Frontiers in Medicine. 10. 1157042–1157042. 4 indexed citations
6.
Lu, Guoyan, et al.. (2023). Association between hyponatremia and adverse clinical outcomes of heart failure: current evidence based on a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 10. 1339203–1339203. 5 indexed citations
7.
Liu, Xiaoliang, Tingting Luo, Zhenxin Fan, et al.. (2023). Single cell RNA-seq resolution revealed CCR1+/SELL+/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166707–166707. 10 indexed citations
8.
Zhang, Xuepeng, Lifan Zhang, Geng Zhang, et al.. (2022). U-shaped association between serum albumin and pediatric intensive care unit mortality in critically ill children. Frontiers in Nutrition. 9. 931599–931599. 5 indexed citations
9.
Ji, Yi, Siyuan Chen, Kaiying Yang, et al.. (2021). A prospective multicenter study of sirolimus for complicated vascular anomalies. Journal of Vascular Surgery. 74(5). 1673–1681.e3. 37 indexed citations
10.
Ji, Yi, Kaiying Yang, Jiangyuan Zhou, et al.. (2021). Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study. Journal of the American Academy of Dermatology. 86(5). 1149–1151. 5 indexed citations
11.
Lu, Guoyan, Hanmin Liu, Deyuan Li, et al.. (2021). Fournier gangrene caused by Escherichia coli complicated with septic shock and sepsis-associated encephalopathy in an 8-month-old girl. Minerva Medica. 114(1). 133–135. 3 indexed citations
12.
Ji, Yi, Siyuan Chen, Kaiying Yang, et al.. (2020). Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study. Journal of the American Academy of Dermatology. 84(5). 1378–1384. 14 indexed citations
13.
Ji, Yi, Siyuan Chen, Jiangyuan Zhou, et al.. (2020). Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management. Orphanet Journal of Rare Diseases. 15(1). 313–313. 13 indexed citations
14.
Liu, Jie, Deyuan Li, Zhongqiang Liu, et al.. (2019). [High-risk factors for early failure of high-flow nasal cannula oxygen therapy in children].. PubMed. 21(7). 650–655. 4 indexed citations
15.
Ji, Yi, Siyuan Chen, Lizhi Li, et al.. (2018). Kaposiform hemangioendothelioma without cutaneous involvement. Journal of Cancer Research and Clinical Oncology. 144(12). 2475–2484. 18 indexed citations
16.
Ji, Yi, et al.. (2018). Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach–Merritt phenomenon: clinical characteristics and management. Cancer Management and Research. Volume 10. 3325–3331. 18 indexed citations
17.
Ji, Yi, Siyuan Chen, Qi Wang, et al.. (2018). Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Scientific Reports. 8(1). 4264–4264. 50 indexed citations
18.
Li, Deyuan, Lili Luo, Min Xu, et al.. (2017). AMPK activates FOXO3a and promotes neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia. Brain Research Bulletin. 132. 1–9. 27 indexed citations
19.
Ji, Yi, Siyuan Chen, Bo Xiang, et al.. (2016). Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Scientific Reports. 6(1). 31744–31744. 25 indexed citations
20.
Wang, Tao, et al.. (2015). Infantile Hepatic Hemangioendothelioma Associated With Congestive Heart Failure. Medicine. 94(52). e2344–e2344. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026